Cancer profiling is a method that improves the accuracy of tumor classification and enables the prediction of a patient's clinical outcome. By identifying
/PRNewswire/ M2GEN, an oncology-focused health informatics solutions company, today announced its participation as a presenter, exhibitor, and research.
/PRNewswire/ Cancer/Tumor Profiling Market size is projected to reach USD 16.0 billion by 2027 from USD 9.7 billion in 2022, at a CAGR of 10.6% during the.